orforglipron glp 1 Orforglipron: Eli Lilly's New Oral GLP-1 Weight-loss Pill Orforglipron | Sterile | CAS

Developing GLP-1 therapies specifically optimized for weight management with enhanced efficacy profiles serves the massive global obesity epidemic beyond traditional diabetes care

Genetic factors influence individual tolerance, which is why personalized approaches yield better outcomes

A synbiotic formulation of Lactobacillus reuteri and inulin alleviates ASD-like behaviors in a mouse model: the mediating role of the gut-brain axis

Answer a few questions about your health and goals, all onlineno in-person doctors office visit necessary

Ferroptosis induction has demonstrated considerable potential to circumvent resistance to targeted therapies, particularly in EGFR-mutant and KRAS-driven LC